133 related articles for article (PubMed ID: 25319848)
1. Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy.
Terashima T; Yamashita T; Iida N; Yamashita T; Nakagawa H; Arai K; Kitamura K; Kagaya T; Sakai Y; Mizukoshi E; Honda M; Kaneko S
Hepatol Res; 2015 Sep; 45(9):949-959. PubMed ID: 25319848
[TBL] [Abstract][Full Text] [Related]
2. Combination of neutrophil-to-lymphocyte ratio and early des-γ-carboxyprothrombin change ratio as a useful predictor of treatment response for hepatic arterial infusion chemotherapy against advanced hepatocellular carcinoma.
Tsunematsu S; Suda G; Yamasaki K; Kimura M; Takaaki I; Umemura M; Ito J; Sato F; Nakai M; Sho T; Morikawa K; Ogawa K; Kamiyama T; Taketomi A; Sakamoto N
Hepatol Res; 2017 May; 47(6):533-541. PubMed ID: 27423140
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil/lymphocyte ratio as a prognostic indicator of hepatic arterial infusion chemotherapy with arterial cisplatin plus continuous 5-fluorouracil.
Tajiri K; Kawai K; Minemura M; Yasumura S; Hosokawa A; Kawabe H; Tomizawa G; Sugiyama T
Hepatol Res; 2015 Jul; 45(7):755-63. PubMed ID: 25196816
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment Neutrophil-to-Lymphocyte Ratio as Prognostic Biomarkers in Patients with Unresectable Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and Camrelizumab.
Xiao Y; Zhu G; Xie J; Luo L; Deng W; Lin L; Tao J; Hu Z; Shan R
J Hepatocell Carcinoma; 2023; 10():2049-2058. PubMed ID: 37965074
[TBL] [Abstract][Full Text] [Related]
5. Combination of psoas muscle mass index and neutrophil/lymphocyte ratio as a prognostic predictor for patients undergoing nonsurgical hepatocellular carcinoma therapy.
Sugama Y; Miyanishi K; Osuga T; Tanaka S; Hamaguchi K; Ito R; Sakamoto H; Kubo T; Ohnuma H; Murase K; Takada K; Kobune M; Kato J
JGH Open; 2021 Dec; 5(12):1335-1343. PubMed ID: 34950776
[TBL] [Abstract][Full Text] [Related]
6. Role and limitation of neoadjuvant hepatic arterial infusion chemotherapy in advanced hepatocelluar carcinoma patients with Child-Pugh class A.
Lee BH; Lee DS; Cho CW; Yun SS
World J Surg Oncol; 2019 Aug; 17(1):143. PubMed ID: 31416447
[TBL] [Abstract][Full Text] [Related]
7. Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma.
Kawaoka T; Aikata H; Hyogo H; Morio R; Morio K; Hatooka M; Fukuhara T; Kobayashi T; Naeshiro N; Miyaki D; Hiramatsu A; Imamura M; Kawakami Y; Takahashi S; Waki K; Tsuji K; Kohno H; Kohno H; Moriya T; Chayama K
J Dig Dis; 2015 Sep; 16(9):505-12. PubMed ID: 26121102
[TBL] [Abstract][Full Text] [Related]
8. The systemic inflammatory response as a prognostic factor for advanced hepatocellular carcinoma with extrahepatic metastasis.
Aino H; Sumie S; Niizeki T; Kuromatsu R; Tajiri N; Nakano M; Satani M; Okamura S; Shimose S; Miyahara K; Torimura T
Mol Clin Oncol; 2016 Jul; 5(1):83-88. PubMed ID: 27330772
[TBL] [Abstract][Full Text] [Related]
9. Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative-intent surgery for hepatocellular carcinoma: experience from a developing country.
Galun D; Bogdanovic A; Djokic Kovac J; Bulajic P; Loncar Z; Zuvela M
Cancer Manag Res; 2018; 10():977-988. PubMed ID: 29765248
[TBL] [Abstract][Full Text] [Related]
10. Peripheral venous blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy.
Chen L; Zuo Y; Zhu L; Zhang Y; Li S; Ma F; Han Y; Song H; Xue Y
Onco Targets Ther; 2017; 10():2569-2580. PubMed ID: 28553122
[TBL] [Abstract][Full Text] [Related]
11. Serum transferrin as a predictor of prognosis for hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma.
Zaitsu J; Yamasaki T; Saeki I; Harima Y; Iwamoto T; Harima Y; Matsumoto T; Urata Y; Hidaka I; Marumoto Y; Ishikawa T; Takami T; Yamamoto N; Kaino S; Uchida K; Terai S; Sakaida I
Hepatol Res; 2014 May; 44(5):481-90. PubMed ID: 23607437
[TBL] [Abstract][Full Text] [Related]
12. Effect of body composition on survival benefit of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: A comparison with sorafenib therapy.
Saeki I; Yamasaki T; Maeda M; Hisanaga T; Iwamoto T; Matsumoto T; Hidaka I; Ishikawa T; Takami T; Sakaida I
PLoS One; 2019; 14(6):e0218136. PubMed ID: 31194789
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
[TBL] [Abstract][Full Text] [Related]
14. Sorafenib versus hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a systematic review and meta-analysis.
Zhuang BW; Li W; Xie XH; Hu HT; Lu MD; Xie XY
Jpn J Clin Oncol; 2019 Sep; 49(9):845-855. PubMed ID: 31063184
[TBL] [Abstract][Full Text] [Related]
15. Comparison of clinical outcomes between sorafenib and hepatic artery infusion chemotherapy in advanced hepatocellular carcinoma: A STROBE-compliant article.
Kang MK; Park JG; Lee HJ
Medicine (Baltimore); 2018 Apr; 97(17):e0611. PubMed ID: 29703062
[TBL] [Abstract][Full Text] [Related]
16. Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular Carcinoma.
Mei J; Li SH; Li QJ; Sun XQ; Lu LH; Lin WP; Zheng L; Chen MS; Shi M; Wei W; Guo RP
J Hepatocell Carcinoma; 2021; 8():167-176. PubMed ID: 33791252
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of hepatic arterial infusion chemotherapy as an alternative to sorafenib in advanced hepatocellular carcinoma.
Jeong SW; Jang JY; Lee JE; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Kim HS; Kim BS; Kim KH; Kim YJ
Asia Pac J Clin Oncol; 2012 Jun; 8(2):164-71. PubMed ID: 22524575
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis.
Li SH; Wang QX; Yang ZY; Jiang W; Li C; Sun P; Wei W; Shi M; Guo RP
World J Gastroenterol; 2017 May; 23(17):3122-3132. PubMed ID: 28533669
[TBL] [Abstract][Full Text] [Related]
19. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases.
Ando E; Tanaka M; Yamashita F; Kuromatsu R; Yutani S; Fukumori K; Sumie S; Yano Y; Okuda K; Sata M
Cancer; 2002 Aug; 95(3):588-95. PubMed ID: 12209752
[TBL] [Abstract][Full Text] [Related]
20. Preoperative neutrophil-to-lymphocyte ratio as a predictor of survival after reductive surgery plus percutaneous isolated hepatic perfusion for hepatocellular carcinoma: a retrospective analysis.
Arai K; Fukumoto T; Kido M; Tanaka M; Kuramitsu K; Kinoshita H; Komatsu S; Tsugawa D; Terai S; Matsumoto T; Goto T; Asari S; Toyama H; Ajiki T; Ku Y
Surg Today; 2017 Mar; 47(3):385-392. PubMed ID: 27465474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
